- Home
- CLEU vs BGLC Comparison
CLEU vs BGLC Comparison
Compare CLEU & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLEU
- BGLC
- Stock Information
- Founded
- CLEU 2011
- BGLC 2017
- Country
- CLEU China
- BGLC Malaysia
- Employees
- CLEU N/A
- BGLC N/A
- Industry
- CLEU Other Consumer Services
- BGLC Medical Specialities
- Sector
- CLEU Real Estate
- BGLC Health Care
- Exchange
- CLEU Nasdaq
- BGLC Nasdaq
- Market Cap
- CLEU 6.4M
- BGLC 7.6M
- IPO Year
- CLEU 2020
- BGLC N/A
- Fundamental
- Price
- CLEU $0.21
- BGLC $0.30
- Analyst Decision
- CLEU
- BGLC
- Analyst Count
- CLEU 0
- BGLC 0
- Target Price
- CLEU N/A
- BGLC N/A
- AVG Volume (30 Days)
- CLEU 182.3K
- BGLC 79.5K
- Earning Date
- CLEU 11-26-2024
- BGLC 11-29-2024
- Dividend Yield
- CLEU N/A
- BGLC N/A
- EPS Growth
- CLEU N/A
- BGLC N/A
- EPS
- CLEU N/A
- BGLC N/A
- Revenue
- CLEU $2,413,409.00
- BGLC $9,259,858.00
- Revenue This Year
- CLEU N/A
- BGLC N/A
- Revenue Next Year
- CLEU N/A
- BGLC N/A
- P/E Ratio
- CLEU N/A
- BGLC N/A
- Revenue Growth
- CLEU N/A
- BGLC N/A
- 52 Week Low
- CLEU $0.20
- BGLC $0.28
- 52 Week High
- CLEU $4.74
- BGLC $3.39
- Technical
- Relative Strength Index (RSI)
- CLEU 29.56
- BGLC 24.52
- Support Level
- CLEU $0.23
- BGLC $0.32
- Resistance Level
- CLEU $0.24
- BGLC $0.38
- Average True Range (ATR)
- CLEU 0.02
- BGLC 0.02
- MACD
- CLEU -0.00
- BGLC -0.00
- Stochastic Oscillator
- CLEU 9.62
- BGLC 18.27
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.